cbdMD, Inc. (YCBD)

USD 0.4

(-9.34%)

Market Cap (In USD)

1.77 Million

Revenue (In USD)

24.15 Million

Net Income (In USD)

-22.93 Million

Avg. Volume

34.09 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.311-1.73
PE
-
EPS
-
Beta Value
1.991
ISIN
US12482W3097
CUSIP
12482W101
CIK
1644903
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. T. Ronan Kennedy
Employee Count
-
Website
https://www.cbdmd.com
Ipo Date
2017-11-17
Details
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.